Have a personal or library account? Click to login
Presentation of Metastatic Colorectal Carcinoma at a Tertiary Care Center in Pakistan Cover

References

  1. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology. 2021;14(10):101174.
  2. Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis. Cancer medicine. 2020;9(1):361–73.
  3. Khan SZ, Lengyel CG. Challenges in the management of colorectal cancer in low- and middle-income countries. Cancer Treatment and Research Communications. 2023;35:100705.
  4. Martin J, Petrillo A, Smyth EC, Shaida N, Khwaja S, Cheow HK, et al. Colorectal liver metastases: Current management and future perspectives. World Journal of clinical oncology. 2020;11(10):761–808.
  5. Global Cancer Observatory - Pakistan 2022 [Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/586-pakistan-fact-sheet.pdf.
  6. Begum S, Khan MR. Need For A National Cancer Registry In Pakistan: Challenges And Way Forward. JPMA The Journal of the Pakistan Medical Association. 2023;73(7):1475–9.
  7. Khan SJ, Asif M, Aslam S, Khan WJ, Hamza SA. Pakistan's Healthcare System: A Review of Major Challenges and the First Comprehensive Universal Health Coverage Initiative. Cureus. 2023;15(9):e44641.
  8. Khokhar MA, Ali MM, Liaqat S, Moin A, Sarwar HA, Sarwar MZ. A review of access to cancer facilities in Punjab, Pakistan. Cancer Rep (Hoboken). 2020;3(3):e1245.
  9. Hasan F, Mahmood Shah SM, Munaf M, Khan MR, Marsia S, Haaris SM, et al. Barriers to Colorectal Cancer Screening in Pakistan. Cureus. 2017;9(7):e1477.
  10. Glover M, Mansoor E, Panhwar M, Parasa S, Cooper GS. Epidemiology of Colorectal Cancer in Average Risk Adults 20–39 Years of Age: A Population-Based National Study. Digestive diseases and sciences. 2019;64(12):3602–9.
  11. Marley AR, Nan H. Epidemiology of colorectal cancer. International Journal of molecular epidemiology and genetics. 2016;7(3):105–14.
  12. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad gastroenterologiczny. 2019;14(2):89–103.
  13. Deo SVS, Kumar S, Bhoriwal S, Shukla NK, Sharma A, Thulkar S, et al. Colorectal Cancers in Low- and Middle-Income Countries—Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India. 2021(7):1110–5.
  14. Hashmi AA, Aslam M, Rashid K, Ali AH, Dowlah TU, Malik UA, et al. Early-Onset/Young-Onset Colorectal Carcinoma: A Comparative Analysis of Morphological Features and Biomarker Profile. Cureus. 2023;15(7):e42340.
  15. Sengupta N, Yau C, Sakthianandeswaren A, Mouradov D, Gibbs P, Suraweera N, et al. Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion. Molecular cancer. 2013;12:1.
  16. Idrees R, Fatima S, Abdul-Ghafar J, Raheem A, Ahmad Z. Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country. World Journal of Surgical Oncology. 2018;16(1):129.
  17. Abro MN, Khan M, Jam M, Maheshwari G, Asghar G, Ahmed S, et al. Incidence of Colorectal Carcinoma in the Remote Area of Sindh, Pakistan. 2023;9:539–46.
  18. Zhang J, Chen G, Li Z, Zhang P, Li X, Gan D, et al. Colonoscopic screening is associated with reduced Colorectal Cancer incidence and mortality: a systematic review and meta-analysis. Journal of Cancer. 2020;11(20):5953–70.
  19. Gimeno-García AZ, Quintero E. Role of colonoscopy in colorectal cancer screening: Available evidence. Best Practice & Research Clinical Gastroenterology. 2023;66:101838.
  20. Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointestinal Endoscopy. 2012;76(1):110–7.
  21. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. 2023;73(3):233–54.
  22. Franzese C, Louie AV, Kotecha R, Zhang Z, Guckenberger M, Kim MS, et al. Stereotactic Body Radiation therapy for Liver Metastases: Systematic Review and Meta-Analysis With International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines. Practical radiation oncology. 2024.
  23. Bordeau K, Michalet M, Keskes A, Valdenaire S, Debuire P, Cantaloube M, et al. Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study. Journal of clinical medicine. 2023;12(3).
  24. Dagenborg VJ, Brudvik KW, Lund-Andersen C, Torgunrud A, Lund-Iversen M, Flatmark K, et al. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer. Annals of surgery. 2024;280(5):745–52.
  25. Min HY, Lee HY. Molecular targeted therapy for anticancer treatment. Experimental & molecular medicine. 2022;54(10):1670–94.
  26. Ahmed RN, Rai L, Samo KA, Saeed S, Salam A, Khan H, et al. Factors affecting delay in diagnosis of colorectal cancer: A cross-sectional study from a tertiary care hospital of Karachi, Pakistan. International Journal of clinical practice. 2021;75(10):e14529.
  27. Lillemoe HA, Vauthey J-NJHS, Nutrition. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. 2019. 2019;9(1):25–34.
  28. Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. The oncologist. 2012;17(10):1225–39.
  29. Zhang C, Patel A, Hegeholz D, Brown K, Shostrom V, Pottebaum M, et al. Cytoreductive Surgery with HIPEC is a Safe and Effective Palliative Option in Chemorefractory Symptomatic Peritoneal Metastasis. Annals of surgical oncology. 2022;29(5):3337–46.
  30. Mansour R, Abdel-Razeq H, Al-Hussaini M, Shamieh O, Al-Ibraheem A, Al-Omari A, et al. Systemic Barriers to Optimal Cancer Care in Resource-Limited Countries: Jordanian Healthcare as an Example. Cancers. 2024;16(6).
  31. Stefan DC, Tang S. Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research. BMC cancer. 2023;23(1):756.
  32. Awan UA, Guo X, Khattak AA, Hassan U, Khan S. Economic crises and cancer care in Pakistan—timely action saves lives. The Lancet. 2024;403(10427):613–4.
  33. Byun JH, Ahn JB, Kim SY, Kang JH, Zang DY, Kang SY, et al. The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study. The Korean Journal of internal medicine. 2019;34(1):165–77.
  34. Duzkale N, Oz O, Turkmenoglu TT, Cetinkaya K, Eren T, Yalcin S. Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience. Journal of the College of Physicians and Surgeons-Pakistan : JCPSP. 2021;31(7):811–6.
  35. Mohamed F, Kallioinen M, Braun M, Fenwick S, Shackcloth M, Davies RJ, et al. Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance. British Journal of Surgery. 2020;107(8):943–5.
Language: English
Page range: 40 - 50
Published on: Oct 17, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Sehar Salim Virani, Muhammad Taha Nasim, Fiza Adnan, Muhammad Ibrahim, Munira Shabbir Moosajee, Muhammad Rizwan Khan, Kulsoom Ghias, Muhammad Murtaza, Sadaf Khan, Syed Nabeel Zafar, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.